Siga Technologies (SIGA) Other Non-Current Assets (2010 - 2025)
Siga Technologies' (SIGA) quarterly Other Non-Current Assets came in at $192893.0 in Q4 2025, down 19.86% on a YoY basis from $240683.0 in Q4 2024, and down 4.52% quarter-over-quarter from $202015.0 in Q3 2025.
Analysis
Siga Technologies (SIGA) Other Non-Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Other Non-Current Assets for 16 consecutive years, with $192893.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Other Non-Current Assets fell 19.86% year-over-year to $192893.0; the trailing twelve-month figure through Dec 2025 stood at $192893.0 (down 19.86% YoY), and the FY2025 full-year result was $192893.0, down 19.86% from the prior year.
- Other Non-Current Assets eased to $192893.0 in Q4 2025 per SIGA's latest filing, from $202015.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.2 million in Q2 2024 and bottomed at $192893.0 in Q4 2025.
- Historically, Other Non-Current Assets has averaged $822755.4 across 5 years, with a median of $276009.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Other Non-Current Assets tumbled 97.43% in 2021, then jumped 749.77% in 2023.
- Over 5 years, Other Non-Current Assets stood at $286585.0 in 2021, then retreated by 11.88% to $252546.0 in 2022, then jumped by 725.01% to $2.1 million in 2023, then sank by 88.45% to $240683.0 in 2024, then fell by 19.86% to $192893.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $192893.0, $202015.0, and $212696.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 9.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 5.50 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 42.45 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 86.76 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 239.50 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 192,893.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 192,893.00 |
| Sep 30, 2025 | 202,015.00 |
| Jun 30, 2025 | 212,696.00 |
| Mar 31, 2025 | 226,485.00 |
| Dec 31, 2024 | 240,683.00 |
| Sep 30, 2024 | 253,605.00 |
| Jun 30, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.08 Mn |
| Sep 30, 2023 | 2.14 Mn |
| Jun 30, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 252,546.00 |
| Sep 30, 2022 | 261,814.00 |
| Jun 30, 2022 | 249,170.00 |
| Mar 31, 2022 | 265,433.00 |
| Dec 31, 2021 | 286,585.00 |
| Sep 30, 2021 | 306,722.00 |
| Jun 30, 2021 | 392,665.00 |
| Mar 31, 2021 | 419,448.00 |